|
SRBD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.994600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.828400E-01 |
| Normal-vs-Stage2 |
6.540400E-01 |
| Normal-vs-Stage3 |
6.924800E-01 |
| Normal-vs-Stage4 |
8.572000E-01 |
| Stage1-vs-Stage2 |
4.606800E-01 |
| Stage1-vs-Stage3 |
4.553000E-01 |
| Stage1-vs-Stage4 |
9.776000E-01 |
| Stage2-vs-Stage3 |
9.381400E-01 |
| Stage2-vs-Stage4 |
6.683800E-01 |
| Stage3-vs-Stage4 |
6.911800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.511600E-01 |
| Normal-vs-AfricanAmerican |
9.092800E-01 |
| Normal-vs-Asian |
7.602200E-01 |
| Caucasian-vs-AfricanAmerican |
9.875600E-01 |
| Caucasian-vs-Asian |
7.073400E-01 |
| AfricanAmerican-vs-Asian |
7.144200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.012600E-01 |
| Normal-vs-Female |
5.327500E-02 |
| Male-vs-Female |
4.018800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.572800E-01 |
| Normal-vs-Extreme_Weight |
7.429900E-02 |
| Normal-vs-Obese |
3.606200E-01 |
| Normal-vs-Extreme_Obese |
9.305600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.303400E-01 |
| Normal_Weight-vs-Obese |
2.952400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.673600E-01 |
| Extreme_Weight-vs-Obese |
2.594100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.047600E-01 |
| Obese-vs-Extreme_Obese |
7.602800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.037000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.039800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.531000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.516200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.306800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.094800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.497600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.784200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.623400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.079000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.491800E-01 |
| Normal-VS-Type2 PRCC |
3.989400E-01 |
| Normal-VS-KIRP CIMP |
9.087000E-01 |
| Normal-VS-Unclassified PRCC |
7.164300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.563400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.341600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.910200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.576800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.988200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.712800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.825800E-01 |
| Normal-vs-N1 |
5.949400E-01 |
| Normal-vs-N2 |
1.537210E-01 |
| N0-vs-N1 |
3.579200E-01 |
| N0-vs-N2 |
6.769400E-01 |
| N1-vs-N2 |
4.350800E-01 |
|
|
